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Mice with the K644E kinase domain mutation in fibroblast growth factor receptor 3 (Fgfr3) (EIIa;Fgfr3+/K644E) exhibited a marked
enlargement of the brain. The brain size was increased as early as E11.5, not secondary to the possible effect of Fgfr3 activity in the skeleton.
Furthermore, the mutant brains showed a dramatic increase in cortical thickness, a phenotype opposite to that in FGF2 knockout mice.
Despite this increased thickness, cortical layer formation was largely unaffected and no cortical folding was observed during embryonic days
11.5–18.5 (E11.5–E18.5). Measurement of cortical thickness revealed an increase of 38.1% in the EIIa;Fgfr3+/K644E mice at E14.5 and the
advanced appearance of the cortical plate was frequently observed at this stage. Unbiased stereological analysis revealed that the volume of
the ventricular zone (VZ) was increased by more than two fold in the EIIa;Fgfr3+/K644E mutants at E14.5. A relatively mild increase in
progenitor cell proliferation and a profound decrease in developmental apoptosis during E11.5–E14.5 most likely accounts for the dramatic
increase in total telecephalic cell number. Taken together, our data suggest a novel function of Fgfr3 in controlling the development of the
cortex, by regulating proliferation and apoptosis of cortical progenitors.
D 2004 Elsevier Inc. All rights reserved.
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Cortical development is a complex process that involves
the coordinated actions of cell proliferation, cell fate
specification, migration and further cell maturation. The
cortex originates from the neuroepithelium, a sheetlike
structure that surrounds the ventricular cavity, where
proliferation of self-renewing progenitor cells establishes a
founder population of cortical cells in the ventricular zone
(VZ) (Caviness et al., 1995). In mice, cortical progenitors are
known to go through 11 cell cycles during the 6-day period
between E11 and E17 (Takahashi et al., 1995). Both intrinsic
and extrinsic factors regulate the behaviour of cortical0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.11.035
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E-mail address: t.iwata@beatson.gla.ac.uk (T. Iwata).progenitors (Edlund and Jessell, 1999) and their deve-
lopmental changes are likely to be driven by the diversity
of input signals as well as how cells respond to these signals
(Temple, 2001). FGF2 is one such extrinsic factor (Temple
and Qian, 1995) that plays an important role in neocortical
development. Indeed, the Fgf2 null mouse displays signifi-
cant reductions in neuronal density and, most strikingly, in
cortical thickness (Dono et al., 1998; Raballo et al., 2000).
Responsiveness of cells to FGF is controlled by
membrane receptors, including the high-affinity FGF
receptors (FGFRs), the low-affinity heparin sulphate pro-
teoglycans (HSPGs) and a cysteine-rich FGF receptor
(Szebenyi and Fallon, 1999). FGFRs are membrane tyrosine
kinases encoded by four genes (FGFR1–4) (Schlessinger,
2000). Binding of FGF to the extracellular ligand-binding
domain causes receptor dimerisation. The resulting auto-279 (2005) 73–85
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via molecules including mitogen-activated protein kinase
(MAPK) and phospholipase Cg. FGF2 is a potent mitogenic
ligand for FGFR1–3 in vitro (Ornitz et al., 1996). These
three receptors are expressed in partly overlapping areas of
the embryonic neuroepithelium, however, with distinct
patterns and intensities (Orr-Urtreger et al., 1991; Peters et
al., 1993). Furthermore, the expression pattern of each
receptor becomes more distinct in the adult stages (Yazaki
et al., 1994), indicating their role in specific populations of
cortical cells. Mice with complete deletion of Fgfr1 and
Fgfr2 die early in development (Arman et al., 1998; Deng et
al., 1994; Yamaguchi et al., 1994). In contrast, conditional
knockout studies of Fgfr1 using Foxg1, En1 and Wnt1-Cre
mice show its role in the development of the auditory sensory
epithelium, mid- and hindbrains, and olfactory bulb morpho-
genesis (Hebert et al., 2003; Pirvola et al., 2002; Trokovic et
al., 2003). Fgfr3 null mice show bone and inner ear defects in
adult stages (Colvin et al., 1996; Deng et al., 1996). Although
no obvious brain phenotype was originally reported, func-
tions of Fgfr3 in glia have recently been indicated. It has been
shown that Fgfr3 represses glial fibrillary acid protein
(GFAP) expression in grey matter astrocytes in the adult
spinal cord (Pringle et al., 2003) and promotes the differ-
entiation of oligodendrocytes and myelination at early
postnatal stages (Oh et al., 2003). A recent study has
examined the role of FGFRs using a truncated dominant-
negative form of FGFR1 (tFgfr1) that inhibits the FGF
signalling downstream of all FGFR subtypes (Shin et al.,
2004). Transgenic mice expressing tFgfr1 under the control
ofOtx1 promoter showed a decreased thickness in the frontal
and temporal cortex, indicating that high-affinity FGFRs
indeed mediate the effect of FGF2 in regulation of the cortical
size. Despite these studies, the FGFR subtype that regulates
the cortical volume in response to FGF2 remains unknown.
Previously, we generated mice with kinase domain
mutations in the Fgfr3 gene (Iwata et al., 2000, 2001).
These mutations at the residue K644 (K650 in humans) are
shown to constitutively activate the tyrosine kinase activity
of Fgfr3 (Iwata et al., 2001; Naski et al., 1996; Webster et
al., 1996). In the Fgfr3 knockout mice, it is possible that the
activities of other FGFR members may have masked the
result of Fgfr3 deletion during central nervous system
(CNS) development. In contrast, the gain-of-function model
may be potentially useful allowing further investigation of
Fgfr3 functions. An observation of a notably rounded head
at postnatal day 1 (P1) in mice with the K644E mutation in
Fgfr3 prompted us to explore their brain phenotype. We
show here that the increased size of the head region in these
mice is caused by a significant increase in brain size.
Subsequently, we focused upon identifying the mechanism
underlying the increased brain size observed in mice with
K644E mutation during embryonic development. Our data
strongly indicate that Fgfr3 plays a role in brain develop-
ment, by regulating its size through controlling proliferation
and apoptosis of cortical progenitors.Materials and methods
Mice and genotyping
Generation, breeding and genotyping of the Fgfr3+/K644E
mice was described previously (Iwata et al., 2000). The
background of EIIa;Fgfr3+/K644E mice is C57/Bl6;129;
FBV/N. All procedures were performed in accordance with
the Project Licence (PPL 60/3060) under the Home Office
Animal (Scientific Procedures) Act 1986.
Histology
The tissues were fixed overnight in 4% paraformalde-
hyde at 48C, processed for paraffin embedding by standard
methods. Sections (8 Am) were mounted on siliconated
glass slides. Sections were subsequently deparaffinised in
Histoclear (Fisher) and rehydrated in graded ethanols.
Haematoxylin and Eosin staining (H&E) was performed
by staining with haematoxylin for 4 min and rinsed with
water. Slides were immersed briefly in 1% HCl in 70%
ethanol followed by Scott’s Tap Water Stain (Surgipath) for
1 min, washed in water and counterstained with eosin for 30
s. Whole-skeleton staining with Alizarin Red S and Alcian
Blue was performed as previously described (McLeod,
1980).
Immunohistochemistry
Endogenous peroxidase activity was blocked by immers-
ing sections in cold 0.3% hydrogen peroxide prepared in
methanol for 20 min. Sections were blocked at room
temperature for 1 h in 10% normal horse serum, 0.5%
bovine albumin and 0.3% Triton X-100. The primary
antibody was applied overnight at 48C and the secondary
for 1 h at room temperature. When using Map2 antibodies, a
0.3% Triton X-100 wash step was included following
secondary antibody incubation. The immunoreactivity was
visualised by Vectastain mouse IgG ABC kit (Vector
Laboratories) and 3,3V-diaminobenzidine (DAB) (Dako) in
the presence of nickel sulphate. Primary antibodies used
were Map2 (HM-2, 1:1000; Sigma) and p-Histone H3
(1:200; Upstate). All antibody dilutions were prepared in
blocking solutions.
Cortical neuron culture
Twenty-two-millimetre-diameter glass coverslips
(Chance Propper, UK) were coated with 1 mg/ml poly-l-
lysine (Sigma). Forebrains from E14.5 littermates were
dissected and trypsinised (0.25% trypsin in 1 mM EDTA) at
378C for 15 min. Following three washes with Minimum
Essential Medium (MEM) (Gibco) supplemented with 0.6%
glucose, 2 mM glutamine and 10% horse serum (HS-
MEM), cells were dissociated by passing through three
Pasteur pipettes with gradually reduced-sized tips. Cells
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was replaced with MEM supplemented with 1% egg
albumin, 1% pyruvic acid, 0.6% glucose, 2 mM glutamine,
20 nM progesterone, 100 AM putrescine, 30 nM selenium
dioxide and 0.1 mg/ml transferin (N2-MEM) at 378C and
5% CO2.
BrdU and TUNEL assays
In vivo 5-bromo-2V deoxyuridine (BrdU) incorporation
assays were performed by intraperitoneally injecting a
time-mated pregnant female with 50 Ag/g body weights of
BrdU (Sigma) in phosphate-buffered saline (PBS). The
offspring were collected after 1 h and embryonic brains
were fixed overnight in 4% paraformaldehyde at 48C. Ten-
micrometre coronal cryosections were prepared following
30% sucrose/PBS treatment and embedding in OCT
(BDH). After brief fixation with 4% paraformaldehyde
for 5 min, DNA was denatured by incubating sections in 2
M HCl for 30 min at 378C. Sections were treated in cold
0.3% hydrogen peroxide prepared in methanol for 10 min
and blocked at room temperature for 45 min in 10%
normal goat serum in PBS. Incubation with the anti-BrdU
mouse monoclonal antibody (B-44, 1:500; BD Bioscien-
ces) was performed overnight at 48C. Incubation with the
secondary antibody and visualisation was as described in
the Immunohistochemistry section. The numbers of BrdU
positive cells were identified as follows. Sections at
equivalent rostrocaudal levels of the forebrain were selected
based on morphological landmarks (N = 4 each of the
genotype). A 2.5 Am  15 Am counting box was randomly
placed within the VZ at E12.5. Ten counting boxes were
used per section. The number of BrdU positive cells in each
counting box was recorded and presented as a percentage of
the total cell number.
Apoptosis was assayed in tissues by heating sections in a
microwave oven for 1 min in 0.1 M citric acid (pH 6) and
blocked in PBS containing 20% normal bovine serum and
3% bovine albumin for 30 min before TUNEL reaction for
1 h at 378C. TUNEL assays in cortical neuron culture were
performed using the In situ Cell Death Kit-AP (Roche).
500,000 cells were plated on coated coverslips. Cells were
fixed in 4% paraformaldehyde for 1 h at 208C and
permeabilised in 0.1% Triton X-100, 0.1% sodium citrate
for 2 min at 48C. The DNA strand breaks were fluores-
cently labelled via the TUNEL reaction for 1 h at 378C.
TUNEL-positive cells were detected by fluorescence
(FITC, 520 nm). Results were documented using a
Zeiss Axioskop microscope and Axiovision software (Carl
Zeiss Ltd).
Estimation of total cell number, volume and cortical
thickness
For estimating total cell numbers from the dissociated
brains, the two telencephalic vesicles (cerebral hemi-spheres) of the Fgfr3 mutant mice and its wild-type
littermates were dissected out, pooled by each genotype,
trypsinised and dissociated. Each litter contained more
than two embryos of each genotype. Estimates of regional
volume, cortical thickness and cell number were obtained
blind to genotype via unbiased stereological methods as
described in Bible et al. (2004) and Raballo et al.(2000)
using StereoInvestigator software (MicroBrightField). One
series of coronal sections (10 Am) was selected from each
brain and stained with H&E. Actual section thickness was
measured by Z-axis encoder and the mean thickness was
identified as 4.5 Am. The first section in a series was
selected at random and subsequently every tenth section
was analysed. Boundaries of regions of interest were
drawn for each section in the series using a 2.5
objective. A counting grid (40 Am) was superimposed
over the drawing of each section and the volume was
estimated using the Cavalieri method. For cortical thick-
ness, coronal sections at equivalent rostrocaudal levels
were selected on the basis of morphological landmarks.
At E12.5, sections at the level posterior to pallidal
protrusion and at the presence of lamina terminalis (E12
plate 4 in Jacobowitz and Abbott, 1997) were selected. At
E14.5, sections at the level posterior to septal and pallidal
forks of lateral ventricle and at the beginning of the
appearance of 3rd ventricles and choroids plexus (E13/
E14 plate 4 in Jacobowitz and Abbott, 1997) were
selected. The cortical thickness was determined by
drawing 30 perpendicular lines per sample across the
width of the pia and ventricular surface using a 5
objective. The unbiased optical fractionator method was
used to estimate the total cell number. Cell nuclei in the
H&E stained sections were counted in a sampling box
with a frame area of 1200 Am2 at a grid area of 22,500
Am2 using a 100 oil objective, between the sections at
the beginning of olfactory ventricles (E13/14 plate 2) and
at the end of lateral ventricles (E13/14 plate 9)
(Jacobowitz and Abbott, 1997). The volume and cell
number in the text represents the value of two hemi-
spheres. The reported values in the literature (Raballo et
al., 2000) appeared higher than the volume and total cell
number obtained by unbiased stereological methods in
this study. The differences in these values may have been
caused by the fact that our measurements were performed
between the landmarks described above and may not
include the most anterior and posterior portions of the
dorsal VZ, as well as by the difference in the background
of animals.
Statistics
Mann–Whitney U test and Student’s t test were
performed to test the significance of difference in numerical
data as appropriate. The data in the text represents bmean F
standard error (SEM)Q. SEM also represents the error bars in
the graphs.
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The K644E kinase domain mutation in Fgfr3 leads to an
increased brain size from an early stage of cortical
development
In mice with the K644E kinase domain mutation in Fgfr3
(Iwata et al., 2000), ubiquitous expression of the mutatedFig. 1. Increased brain size in the EIIa;Fgfr3+/K644 mutant mice. (A) The cond
(EIIa;Fgfr3+/K644E) is indicated. The Cre-loxP recombination was used to overcom
al., 2000). The point mutation K644E (asterisk) corresponding to human K650E w
loxP sites through homologous recombination. Insertion of the neo in the intron
therefore, Fgfr3+/K644Eneo is phenotypically normal and fertile. These mice are the
in mice with the mutant phenotype. Owing to an abnormal rib cage, these mice die
evident at E18.5 in the dissected tissues (B) and in coronal sections (C). CI; cortex
ventricle. (D) Skeletal staining of E13.5 embryos showed that cartilaginous conde
bones of the skull vault were not formed at this stage either in the wild type and EII
at E12.5 (E) and at E11.5 (F) showing enlarged head areas. The overall brain reg
arrow in E). At E11.5, larger size of the mesencephalon as well as telencephalon
phenotype (white arrows highlight eye level in F). (G) Enlargement of the neuro
increase in the surface area of the VZ (arrows in G) did not cause any obvious fo
Coronal sections at equivalent rostrocaudal level in the embryonic forebrain at E12
wild-type littermates. t; telencephalon, ms; mesensephalon, mhb; midbrain–hind
striatum, p; pallidum. Scale bar, 300 Am in (G).Fgfr3 allele was achieved by a cross with a transgenic
mouse with Cre recombinase driven by EIIa promoter
(EIIa;Fgfr3+/K644E) (Fig. 1A). As we described previously,
mice heterozygous with the mutation die within a few hours
of birth, most likely owing to narrowing of the rib cage
(Iwata et al., 2000). A rounding of the head area was ob-
served in all cases of the EIIa;Fgfr3+/K644E genotype (N N
94), but was not apparent in control genotypes (N N103).itional cross strategy to obtain the Fgfr3 mutant mice used in this study
e neonatal lethality caused by the dominant effect of the mutation (Iwata et
as inserted to the Fgfr3 gene locus together with the neo gene flanked by
leads to a transcriptional repression of the mutant allele (Li et al., 1999);
n mated with EIIa-Cre transgenic mice in order to remove the neo, resulting
within a day of birth. (B,C) Enlargement of the EIIa;Fgfr3+/K644E brain was
layer I, CxP; cortical plate, cp: caudoputamen, H; hypothalamus, 3V; third
nsation was already present and stained blue (black arrows). However, the
a;Fgfr3+/K644E embryos (red arrows). (E,F) The EIIa;Fgfr3+/K644E embryos
ion was larger in the EIIa;Fgfr3+/K644E mouse including spinal cord (white
was already noticeable. Lower-set eyes particularly were indicative of this
epithelium and ventricles in the EIIa;Fgfr3+/K644E Fgfr3 mutant mice. The
lding of the cortical surface during the stages we examined (E12.5–E18.5).
.5 were stained by H&E. Samples are from +/E; EIIa;Fgfr3+/K644E and Wt;
brain boundary, LV; lateral ventricle, h; hippocampus, nc; neocortex, s;
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the head was most likely caused by an increased brain size
of the EIIa;Fgfr3+/K644E mice (Fig. 1B). Areas, including
mid-, hindbrain and the spinal cord, were proportionally
much larger than those of wild-type littermates at E18.5.
This was also observed in the hippocampus and hypoth-
aglamus (Fig. 1C). We next examined the EIIa;Fgfr3+/K644E
embryos at different stages of development in order to
determine how brain enlargement was initiated during the
course of development. Enlargement of the CNS was
apparent in the areas of telencephalon, mesencephalon and
spinal cord as early as E11.5 (Figs. 1E,F). In mice, Fgfr3 is
highly expressed in the spinal cord at E9.5 and in the VZ of
telencephalon, diencephalon and mylencephalon at E10.5
(Peters et al., 1993). Therefore, these areas of enlargement
in the developing EIIa;Fgfr3+/K644E brains are in accord-
ance with the reported expression pattern of Fgfr3. Enlarged
neuroepithelium and ventricles were also observed in the
EIIa;Fgfr3+/K644E mice at E12.5; however, no cortical
folding was observed at all stages examined during
E11.5–E18.5 (Fig. 1G and data not shown).
To date, the most widely studied function of Fgfr3 is as a
negative regulator of bone growth in both adult (Deng et al.,
1996) and during embryonic stages (Iwata et al., 2000,
2001). In order to address whether skull bone formation
may have influenced the observed CNS phenotype, we
performed a whole-mount skeletal stain. The earliest of the
skull vault bones to form are the frontal bones which appear
around E14 in mice (Kaufman and Bard, 1999). Skeletons
stained at E13.5 indeed demonstrated that no skull bones
were present at this stage either in wild-type or theFig. 2. Increased cortical thickening in the EIIa;Fgfr3+/K644 mutant mice at E18.5
proportionately increased in thickness by the K644E mutation (B–G in higher mag
exception of layer I (B, C). Additional abnormalities in cellular patterns were obser
cortex appeared clustered compared to those in the wild type littermate (arrowhead
EIIa;Fgfr3+/K644E compared with wild type (F, G). CI–CVI; cortex layers I–VI, S
from +/E; EIIa;Fgfr3+/K644E and Wt; wild-type littermates. A–G, H&E stain. ScaEIIa;Fgfr3+/K644E mice (Fig. 1D). As the heads of the
EIIa;Fgfr3+/K644E mice are larger than those of the wild-
type littermates as early as E11.5 (Figs. 1E,F), skull bones
are unlikely to be the initial cause of enlargement in the
head area and in the brains of the EIIa;Fgfr3+/K644E mice.
We further addressed this issue by performing a cross with a
Collagen type 2 (Col2)-Cre mouse that restricts expression
of the Fgfr3 mutant allele in skeletal tissues. The resulting
Col2; Fgfr3+/K644E mice showed no CNS enlargement (data
not shown and Lin et al., 2003). Furthermore, the cross with
a nestin-Cre mouse, leading to an expression of phenotype
only in the CNS, showed an increased brain size in the
absence of the skeletal phenotype (Lin et al., 2003). From
these observations, we concluded that the increased head
area and brain size observed in the EIIa;Fgfr3+/K644E mice
was primarily caused by a brain-specific function of Fgfr3.
Cortical thickening and advanced development of the
EIIa;Fgfr3+/K644E cortex emerge between E12.5 and E14.5
We observed a significant increase in cortical thickness
in the EIIa;Fgfr3+/K644E mice at E18.5 (Fig. 2A). To gain
further insight into the mechanism underlying this pheno-
type, we have further examined the dorsal cortical region of
the forebrains in the EIIa;Fgfr3+/K644E mice in more detail.
The increased thickness of the cortex appeared across all
layers without significantly disturbing their overall organ-
isation. The exception was the layer I, where no apparent
change in thickness was present (Figs. 2B,C). In addition,
the EIIa;Fgfr3+/K644E cortex showed increased clustering of
cells in the intermediate zone (IZ) (arrowheads in Figs.. (A) Sagittal sections of E18.5 brains showed that all cortical layers appear
nification of A, wild type in B, D, F; EIIa;Fgfr3+/K644E in C, E, G), with the
ved in the EIIa;Fgfr3+/K644E cortex; Cells in the IZ of the EIIa;Fgfr3+/K644E
s in A, E) and the junction between the SVZ and the IZ was irregular in the
P; subplate, IZ; intermediate zone, SVZ; subventricular zone. Samples are
le bar, 90 Am in (A), 25 Am in (B, C), 30 Am in (D–G).
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IZ (Figs. 2F,G). The reasons for the disorganisation of the
layer boundaries and clustering of cells in the IZ observed at
the later embryonic stages (E16.5–E18.5) (Fig. 3C) are
currently unclear.
During embryonic development, the cortex undergoes
dynamic changes to ultimately form its typical laminar
structure (Sidman and Rakic, 1973). In order to assess the
timing of initial changes occurring in the EIIa;Fgfr3+/K644E
cortex, we examined its morphology at stages between
E12.5 and E16.5. Although there were no significant
changes at E12.5 (Fig. 3A), an increase in cortical thickness
was noted by E14.5 (Fig. 3B). Cortical thickening and
disorganisation of laminar boundaries were subsequently
apparent in the EIIa;Fgfr3+/K644E mice by E16.5 (Fig. 3C).
The cortical thickness was further measured in coronal
sections through the medial forebrain at E12.5 and E14.5
in the wild-type and EIIa;Fgfr3+/K644E mice (see Materials
and methods section for a detailed description of the
morphological landmarks used) (Fig. 3H). The cortical
thickness was significantly increased by 38.1% in theFig. 3. Cortical thickening and advanced cortical plate formation in the EII
EIIa;Fgfr3+/K644E embryos showed no significant changes in cortical thickness an
of the cortical was apparent in the EIIa;Fgfr3+/K644E cortex by E14.5. In addition
brain prior to that of the wild-type littermates. (C) The E16.5 EIIa;Fgfr3+/K644E co
obvious between IZ, SVZ and Ventricular Zone (VZ). MZ; marginal zone, PP; p
Expression of neuronal marker, Map2, was examined by immunohistochemistr
EIIa;Fgfr3+/K644E (E, G) and wild-type littermates (D, F). Map2 was normally expr
E14.5 (F). The area of Map2 staining in the EIIa;Fgfr3+/K644E cortex was c
distributions as the cortex developed further at E14.5 (G). (H) Cortical thickness
and the EIIa;Fgfr3+/K644E brains. Measurements revealed a 38.1% increase in cort
asterisk), although the difference between the genotype was not significant (ns) atEIIa;Fgfr3+/K644E mice at E14.5 (wt; 416 F 47.9 Am,
EIIa;Fgfr3+/K644E; 574 F 18.6 Am, N = 4 each, P b 0.05),
although the difference was not significant at E12.5 (wt;
316 F 13.4 Am, EIIa;Fgfr3+/K644E; 295 F 14.8 Am, N = 3
each). Unbiased Cavalieri estimates of the volume of the
VZ at E14.5 showed more than two-fold increase in
EIIa;Fgfr3+/K644E cortex compared to the wild type (wt;
38.0 F 8.2  106 Am3, EIIa;Fgfr3+/K644E; 91.6 F 19.4 
106 Am3, N = 4 each, P b 0.05).
Interestingly, we frequently observed the advanced
formation of the cortical plate in the EIIa;Fgfr3+/K644E
brains at E14.5 that appeared to split the preplate into the
MZ and the subplate (Fig. 3B). However, overall laminar
organization was largely normal in the EIIa;Fgfr3+/K644E
mice within the context of the molecular markers tested,
including Hes1 (Sasai et al., 1992) and Tbr1 (Bulfone et al.,
1995; Hevner et al., 2001) (data not shown). Immunohis-
tochemistry using neuronal markers microtubule-associated
protein 2 (Map2) (Figs. 3D–G) and NeuN (data not shown)
revealed the distribution of staining corresponding to
cortical morphology. No significant difference between thea;Fgfr3+/K644E forebrain emerging between E12.5 and E14.5. (A) The
d structure compared to the wild-type littermates at E12.5. (B) Thickening
, cortical plate formation was frequently observed in the EIIa;Fgfr3+/K644E
rtex was already thicker than that of the wild type and the boundary was less
replate, CxP, SP, IZ, SVZ as defined in Fig. 2. H&E stain in A–C. (D–G)
y in dorsal forebrain sections at E12.5 (D, E) and E14.5 (F, G) of the
essed in the MZ at E12.5 (D) and it extended widely into the cortical plate at
omparable to that in the wild type at E12.5 (E), and was increased in
was quantified at E12.5 and E14.5 in the dorsal cortex of both wild type
ical thickness in the EIIa;Fgfr3+/K644E mice at E14.5 (N = 4 each, P b 0.05,
E12.5. Scale bar, 50 Am in (A–C), 25 Am in (D, E), 35 Am in (F, G).
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when stained with makers of either radial glia (RC2) or
astrocytes (GFAP) (data not shown).
Increased progenitor cell proliferation in the
EIIa;Fgfr3+/K644E cortex
Next we investigated whether cell numbers were
increased in the EIIa;Fgfr3+/K644E brain. By estimating
the total cell number from the dissociated brains, the
telencephalic vesicles of the EIIa;Fgfr3+/K644E mice con-
tained almost twice the number of cells when compared to
their littermates at E14.5 (wt; 8.46 F 0.73  106 cells,
EIIa;Fgfr3+/K644E; 16.2 F 1.0  106 cells, N = 7 litters for
each genotype, P b 0.001). Furthermore, optical fractio-
nator estimates of the number of cells in the dorsal VZ at
E14.5 revealed a marked increase of 1.6 fold in the
EIIa;Fgfr3+/K644E mice compared to the wild type (wt;
13.2F 3.0 104 cells, EIIa;Fgfr3+/K644E; 18.6F 7.7 104
cells, N = 4 each), although due to high interanimal
variation, this difference did not reach statistical signifi-
cance (data not shown). In order to identify the cause of
the increase in total cell number in the EIIa;Fgfr3+/K644E
brain, we first investigated cell proliferation in the cortex
by an in vivo BrdU incorporation assay, which labels cells
in S-phase (Figs. 4A,B). A mild but significant increase in
proliferating cells by 10.7% was observed at E12.5 (wt;
60.8 F 1.6% total cells, EIIa;Fgfr3+/K644E; 67.3 F 1.6%
total cells, N = 4 each, P b 0.01) (Fig. 4C).
There are two areas in the neocortex where proliferation
of cortical progenitors occurs, the pseudostratified ventric-
ular epithelium (PVE) that closely corresponds to the VZ,
and the secondary proliferative population (SPP) that
extends from the interface of the VZ/SVZ to the IZ
(Takahashi et al., 1993). In order to visualise mitotic events
in relation to their location, we used an M-phase marker,
p-Histone H3. The wild-type cortex showed cells under-
going mitosis along the basal edge of the VZ at E12.5 (Figs.
4D,F) and at E14.5 (Figs. 4H,J). In addition, a few cells at the
upper regions of the VZ and the MZ were stained with the
marker, most likely representing the initial development of
the area of the SPP. A similar staining pattern was observed
in the EIIa;Fgfr3+/K644E neuroepithelium at E12.5 (Figs.
4E,G) and at E14.5 (Figs. 4I,K). Quantitatively, mitotic
cells in the EIIa;Fgfr3+/K644E VZ were increased by 26.1%
(N = 6, P b 0.01) and 38.5% (N = 6, P b 0.01) at E12.5 and
E14.5, respectively (Fig. 4L). Cell division in the SPP was
also significantly increased in the EIIa;Fgfr3+/K644E neuro-
epithelium compared with the wild-type littermate, by 80.6%
(N = 6, P b 0.01) and 65.0% (N = 6 each, P b 0.01) at E12.5
and E14.5, respectively (Fig. 4M). Interestingly, upon closer
inspection, we have observed p-Histone H3 positive cells
in pairs in the SPP, which may highlight cells that have
undergone symmetric terminal divisions generating neu-
rons (arrows in Figs. 4G,K). The number of paired cells in
the SPP was increased in the EIIa;Fgfr3+/K644E micecompared to the wild type by 2.7- and 2.1-fold at E12.5
(wt; 5.3 F 1.0 cells/100 Am2, EIIa;Fgfr3+/K644E; 14.1 F
1.4 cells/100 Am2, N = 6 each, P b 0.001) and E14.5 (wt;
4.4 F 0.72 cells/100 Am2, EIIa;Fgfr3+/K644E; 9.7 F 0.98
cells/100 Am2, N = 6 each, P b 0.01), respectively.
Reduced developmental apoptosis in the
EIIa;Fgfr3+/K644E mice
FGF2 has been shown to act as a survival factor in
neuronal populations in vitro (Szebenyi and Fallon, 1999).
However, its influence on apoptosis that occurs during CNS
development (Kuan et al., 2000) remains unclear. In order to
elucidate whether altered apoptosis is involved in the
increased cortical cell number in the EIIa;Fgfr3+/K644E
mice, we performed TUNEL assays. In the E12.5 wild-type
cortex, apoptotic cells were observed in the VZ and MZ
(Fig. 5A). In contrast, only a few TUNEL-positive cells
were present in the EIIa;Fgfr3+/K644E (Fig. 5B). This
reduction was observed in both VZ and MZ, indicating
that the FGFR3 mutation increases the survival of both
young neurons and of progenitors. The number of TUNEL-
positive cells in the anterior forebrain sections in the
EIIa;Fgfr3+/K644E mice was less than half of that in the
wild-type mice from E11.5 to E14.5 (N = 3 each, P b 0.05)
(Fig. 5C). ATUNEL assay was also performed in the E14.5
cortical neuron cultures (Figs. 5D–G). Consistent with the
above observation, apoptosis in the EIIa;Fgfr3+/K644E
culture was reduced to half of the wild type (Fig. 5H),
suggesting that increased cell survival during development
by Fgfr3 activation occurs in the absence of normal cell-to-
cell contact. In order to see if this effect is FGF2-dependent,
the TUNEL assay was performed in cortical neuron cultures
on 1 day in vitro stimulated with FGF2 for 24 h. The
number of apoptotic cells in the wild-type culture under
these conditions remained similar to the levels observed in
Fig. 5H, showing that the FGF2 stimulation did not reduce
the number of apoptotic cells in the wild type to the level
observed in EIIa;Fgfr3+/K644E (data not shown). No further
reduction in apoptosis was observed in the FGF2-treated
EIIa;Fgfr3+/K644E cells (data not shown). These data
indicate that the increase in cell survival in the
EIIa;Fgfr3+/K644E cells is FGF2-independent and that other
FGF family members may serve as a ligand of Fgfr3 for cell
survival.Discussion
Functions of Fgfr3 in the developing brain
In this study, we have characterised the development of
the dorsal neocortex in mice with K644E kinase domain
mutation in Fgfr3 (EIIa;Fgfr3+/K644E) and investigated the
mechanism underlying the increase in brain size. We have
demonstrated that the EIIa;Fgfr3+/K644E mice showed an
Fig. 4. Fgfr3 K644E mutation causes an increased progenitor cell proliferation. (A–C) Cell proliferation was first assessed by an in vivo BrdU incorporation
assay. BrdU was injected into time-mated pregnant females 1 h prior to harvesting embryos at E12.5. BrdU-labelled cells in the S-phase in the dorsal cortex of the
EIIa;Fgfr3+/K644E brain (B) and in the wild type (A). (C) The number of BrdU positive cells and total cells was counted in a randomly chosen fixed-sized
counting box within the VZ and presented as % BrdU positive cells in total cell number. BrdU incorporation was mildly increased in the EIIa;Fgfr3+/K644E cortex
by 10.7% (N = 4 each, P b 0.01, asterisk). (D–M) These mitotic events were further investigated by immunohistochemistry with an M-phase marker, p-Histone
H3, in E12.5 (D–G) and E14.5 neuroepithelium (H–K) in the wild-type (D, F, H, J) and EIIa;Fgfr3+/K644E forebrain (E, G, I, K). (D, E, H, I) are magnified in (F,
G, J, K), respectively. Mitotic cells were present along the basal edge of the VZ (white arrowheads in F, J), in addition to a few positive cells present at the upper
VZ and in MZ, some of which were observed as pairs (black arrows in G, K). (L) Mitotic events in the basal surface of the VZ at E12.5 and E14.5 were quantified
by counting the number of p-Histone H3 positive cells per hemisphere in two nonconsecutive sections from 3 embryos (N = 6 each genotype). The surface
area of the hemisphere was measured using 10 Am2 grid and the density of mitotic cells were calculated and presented as mitotic cell number per 100 Am2.
There was a 26.1% and 38.5% increase in mitotic cells in the EIIa;Fgfr3+/K644E neuroepithelium at E12.5 and E14.5, respectively (N = 6 each, P b 0.01,
asterisks). (M) A significant increase in cell division was also observed in the upper VZ/MZ in the EIIa;Fgfr3+/K644E neuroepithelium compared to the wild-type
littermates, by 80.6% and 65.0%, at E12.5 and E14.5, respectively (N = 6 each, P b 0.01, asterisks). Sections were selected from the equivalent rostrocaudal
levels of the medial forebrain of EIIa;Fgfr3+/K644E brain and its wild-type littermates. Scale bar, 25 Am in (A, B), 30 Am in (D, E, H, I), 25 Am in (F, G, J, K).
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without cortical folding, which was associated with an
increase of total cell number. Our data suggest that Fgfr3may regulate cortical cell number by at least two mecha-
nisms: cell proliferation and developmental apoptosis.
Firstly, an increase in progenitor cell proliferation occurred
Fig. 5. Reduced developmental apoptosis in the EIIa;Fgfr3+/K644E cortex. TUNEL assays were performed in sections (A–C) and in cortical neuron cultures
derived from E14.5 forebrains (D–H). In E12.5 wild-type cortex, TUNEL-positive cells were observed in the VZ and MZ (arrowheads in A). In contrast, only
few were found in the EIIa;Fgfr3+/K644E cortex (B). (C) The total number of TUNEL-positive cells was quantified in sections at equivalent rostrocaudal levels
from E11.5 to 16.5. Three sections were selected for each genotype at each stage and TUNEL-positive cells within 3 randomly chosen sampling boxes of 20 
20 Am in the dorsal cortex including both the VZ and MZ were counted. The relative number of apoptotic cells in the EIIa;Fgfr3+/K644E cortex was reduced to
less than half of that in the wild-type mice between E11.5 and E14.5 (N = 3 each, P b 0.05, asterisks); however, the difference was not statistically significant
between genotypes at E16.5 (N = 3 each, ns). Decreased apoptosis in the EIIa;Fgfr3+/K644E mutants was also apparent in culture at 1 day in vitro (E) compared
to the wild type (D). The presence of cells was visualised by DAPI (F, G). Apoptotic events were calculated as the ratio of cells positive with TUNEL to the
total cell number present in a given area of coverslips (N = 5). A 51.1% reduction in cell death was observed in the EIIa;Fgfr3+/K644E mutants as compared to
the wild type (H). The differences between the wild type and EIIa;Fgfr3+/K644E were statistically significant (asterisks in C, H). Scale bar, 30 Am in (A, B).
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expanding the size of progenitor pool. This may have
consequently increased the production of neurons seen as
proportionally thicker upper cortical layers and an advanced
formation of the cortical plate observed at E14.5 (Fig. 3).
Secondly, a reduction in developmental apoptosis occurred
throughout E11.5–E14.5 in the EIIa;Fgfr3+/K644E cortex
(Fig. 5).
The potential function of Fgfr3 in cortical development is
supported by the following lines of evidence. Firstly, theincreased brain size observed in this study is primarily
caused by the function of Fgfr3 in the brain. Since the
effects of Fgfr3 mutations in the skeleton appear later in
development than they do in the CNS, it appears unlikely
that abnormal skull bones initiate the enlargement of the
brain (Fig. 1). Secondly, our mouse line is likely to represent
a gain-of-function model with a quantitative increase of
FGF signalling. The K644E mutation has been shown to
constitutively activate the kinase activity of Fgfr3 in vitro
(Iwata et al., 2001; Naski et al., 1996; Webster et al., 1996)
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2001). Furthermore, despite the intensive in vitro studies
characterising downstream signalling pathways of the Fgfr3
mutant proteins (Agazie et al., 2003; Hart et al., 2001;
Lievens and Liboi, 2003) and receptor down-regulation
(Lievens and Liboi, 2003; Monsonego-Ornan et al., 2000),
there is, so far, no evidence of qualitative changes being
caused by the kinase domain mutation leading to abnormal
signalling pathway. Thirdly, although no obvious phenotype
has been reported in the Fgfr3 knockout mice during CNS
development (Colvin et al., 1996; Deng et al., 1996), other
members of FGFRs may potentially compensate for the
absence of Fgfr3. It will be interesting to determine whether
Fgfr1 and Fgfr2 play a similar role to Fgfr3 regulating
cortical thickness. Whether changes in Fgfr3 activity
influence the expression of other receptor members is
currently unknown. Co-activation of either two or all of
the receptor subtypes is also possible, and strategies to
eliminate combinations of FGF receptors will ultimately
clarify their individual functions of receptor within the CNS.
Regulation of the cortical size by Fgfr3
During mammalian evolution, the increase in cortical
surface area is thought to occur based on the number of
radial columns (Rakic, 1995). Although some tangentially
migrating postmitotic cells also reside within the dorsal
cortex, the majority of cortical cells are born in the VZ and
migrate radially, forming a radial unit. Therefore, the size of
the progenitor pool is suggested to contribute to the number
of radial columns regulating the size of the cortical surface.
The drastic increase of cortical surface, leading to massive
folding formation in the transgenic mice with overactivated
Wnt/h-catenin signalling (Chenn and Walsh, 2002), was not
observed in our Fgfr3 mutant mice. It was suggested that the
activation of the Wnt/h-catenin signalling may influence the
progenitors to reenter the cell cycle to produce more
progenitors (Chenn and Walsh, 2002). Rather than control-
ling the decision of progenitor cells to re-enter or exit the
cell cycle, increased Fgfr3 signalling may affect the length
of each cell cycle. Alternatively, decreased developmental
apoptosis may contribute more significantly to the pheno-
type observed in our EIIa;Fgfr3+/K644E brain. A recent
study indicated that 89.5% of the progenitors that moved to
SVZ subsequently went through symmetric terminal divi-
sions to generate neurons (Noctor et al., 2004). In this
context, the marked increase in cell division in the
EIIa;Fgfr3+/K644E SPP observed at E12.5 and E14.5 in this
study predicts increased neurogenesis.
It is possible that the enlarged ventricles observed in our
EIIa;Fgfr3+/K644E brains are the result of abnormal homeo-
stasis of cerebrospinal fluid (CSF) (Fig. 1G). The over-
production of CSF by choroid plexus, obstruction of its flow
and reduced CSF absorption by the subarachnoid villi may
each cause increase in ventricular pressure. However,
upon close inspection of the embryonic brains of theEIIa;Fgfr3+/K644E mice, no obvious structural abnormalities
that may obstruct the CSF flow were present and the
meninges looked normal (Fig. 1G).
Function of Fgfr3 under specific FGF ligands
The phenotype we observed in the EIIa;Fgfr3+/K644E
mouse is opposite to that of FGF2 knockout mice (Dono et
al., 1998; Ortega et al., 1998; Raballo et al., 2000; Vaccarino
et al., 1999), including increased total cortical cell number
and proliferation. The phenotypes observed in the postnatal
Fgf2 null mouse, including less mature and fewer pyramidal
neurons and failure of migration in layer II and III neurons
(Dono et al., 1998; Raballo et al., 2000), were not examined
in this study. Although the expression of FGFR3 is
maintained widely in the adult brain (Belluardo et al.,
1997; Yazaki et al., 1994), we were not able to address these
phenotype in adult mice owing to the perinatal lethality of
the EIIa;Fgfr3+/K644E mutation. Detailed analysis of our
mice produced by the crosses with brain and cell lineage-
specific Cre mice will be useful to address these issues.
FGF members other than FGF2 may also act as a ligand
of Fgfr3 in the CNS. Among those expressed in the CNS,
mitogenic activity of Fgfr3 in BaF3 cells was induced by
FGF1, FGF9 and FGF17, as well as FGF4, FGF8 and
FGF18, to a lesser degree (Ford-Perriss et al., 2001). In
particular, cortical cell survival may be regulated by FGF8.
FGF8 was shown to play an important role in defining
anterior–posterior (AP) patterning, signalling at an isthmic
organiser at the midbrain–hindbrain boundary (Chi et al.,
2003; Martinez et al., 1999), as well as in the forebrain
(Fukuchi-Shimogori and Grove, 2001; Garel et al., 2003). In
addition to the loss of olfactory bulbs and defects in
midbrain and cerebellum, FGF8 hypomorphic knockout
mice that survived to birth showed a smaller-sized forebrain
(Meyers et al., 1998). The mechanism of this phenotype is
unknown. In contrast, the molecular mechanism of midline
formation in the forebrain may involve a transcription
factor, Foxg1, which was shown to be induced by FGF8 in
the ANR (Shimamura and Rubenstein, 1997; Ye et al.,
1998). Foxg1 then restricts the expression of bone morpho-
genetic protein 4 (BMP4) to the midline (Dou et al., 1999),
where apoptosis is induced (Furuta et al., 1997). Further-
more, positive or negative regulation of cell survival is
controlled by the dosage of FGF8 in developing forebrain
(Storm et al., 2003). Although no obvious midline defect
was observed in our EIIa;Fgfr3+/K644Emouse brains, it
would be interesting to see if FGF8, or other FGF family
members, serves as a ligand of Fgfr3 to regulate the
developmental apoptosis in the forebrain cortex.
Abnormal FGF signalling causing CNS disorders in
humans
The abnormal migration of neural cells, as well as altered
neurogenesis and cell survival, may each cause cortical
S.L. Inglis-Broadgate et al. / Developmental Biology 279 (2005) 73–85 83malformation in humans (Ross and Walsh, 2001). The
importance of FGF signalling in the normal cortical
development has only just started to emerge. For example,
brain-specific Fgfr1 null mice showed a lack of olfactory
bulb formation (Hebert et al., 2003) and the loss-of-function
mutation in FGFR1 has been associated with a dominant
form of Kallman syndrome, KAL2 (Dode et al., 2003),
which is characterised by anosmia due to the lack of
olfactory bulb. Moreover, spontaneous and persistent
locomotor hyperactivity observed in the tFgfr1 mice implies
that the FGF signalling is critical for the inhibitory
regulation of motor behaviour (Shin et al., 2004). The
K650E mutation (K644E in mice) in this study causes a
perinatal lethal dwarfism, Thanotophoric Dysplasia type II
(TDII) (OMIM#187600), while K650M causes a slightly
milder disorder, Severe Achondroplasia with Developmen-
tal Delay and Acanthosis Nigricans (SADDAN) (Bellus et
al., 1999; Tavormina et al., 1999). Macrocephaly is
prominent in both cases, and loss of hippocampal structure
was often found in the newborn and fetus with TDII (Ho et
al., 1984; Wongmongkolrit et al., 1983). In addition,
SADDAN patients also show seizures and hydrocephalus
during infancy, leading to severe limitations in motor and
intellectual development. CNS-specific conditional crosses
of our Fgfr3 mutant mice will allow highly informative
functional analysis of the Fgfr3-positive progenitor popula-
tion postnatally. Further investigation of the role of FGF
signalling in cortical progenitor cell cycle and apoptosis are
likely to provide significant insights into the molecular
mechanisms of human brain malformation syndromes and
cognition.Acknowledgments
We thank Biological Services, Molecular Technology,
and Technology Services of the Beatson Laboratories for
Cancer Research, for their support in animal care, genotyp-
ing, and in histology, respectively. We also thank Drs. Sue
Barnett and Lynda Chang for critical reading of the
manuscript and other members of the PSDL for their kind
support. This work was supported by grant BBS/B/08736
from the Biotechnology and Biological Science Research
Council (to T.I). The microscopy equipment and sterology
software in the PSDL was funded by National Institutes of
Health grants NS41930 and NS44310 (JDC), a European
Commission 6th Framework Research Grant LSHM-CT-
2003-503051 (JDC), and grants to JDC from The Natalie
Fund, Batten Disease Support and Research Association,
Batten Disease Family Association and the Remy Fund.References
Agazie, Y.M., Movilla, N., Ischenko, I., Hayman, M.J., 2003. The
phosphotyrosine phosphatase SHP2 is a critical mediator of trans-formation induced by the oncogenic fibroblast growth factor receptor 3.
Oncogene 22, 6909–6918.
Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., Lonai, P.,
1998. Targeted disruption of fibroblast growth factor (FGF)
receptor 2 suggests a role for FGF signaling in pregastrulation
mammalian development. Proc. Natl. Acad. Sci. U. S. A. 95,
5082–5087.
Belluardo, N., Wu, G., Mudo, G., Hansson, A.C., Pettersson, R., Fuxe, K.,
1997. Comparative localization of fibroblast growth factor receptor-1,
-2, and -3 mRNAs in the rat brain: in situ hybridization analysis.
J. Comp. Neurol. 379, 226–246.
Bellus, G.A., Bamshad, M.J., Przylepa, K.A., Dorst, J., Lee, R.R.,
Hurko, O., Jabs, E.W., Curry, C.J., Wilcox, W.R., Lachman, R.S.,
Rimoin, D.L., Francomano, C.A., 1999. Severe achondroplasia with
developmental delay and acanthosis nigricans (SADDAN): pheno-
typic analysis of a new skeletal dysplasia caused by a Lys650Met
mutation in fibroblast growth factor receptor 3. Am. J. Med. Genet.
85, 53–65.
Bible, E., Gupta, P., Hofmann, S.L., Cooper, J.D., 2004. Regional and
cellular neuropathology in the palmitoyl protein thioesterase-1 null
mutant mouse model of infantile neuronal ceroid lipofuscinosis.
Neurobiol. Dis. 16, 346–359.
Bulfone, A., Smiga, S.M., Shimamura, K., Peterson, A., Puelles, L.,
Rubenstein, J.L., 1995. T-brain-1: a homolog of Brachyury whose
expression defines molecularly distinct domains within the cerebral
cortex. Neuron 15, 63–78.
Caviness Jr., V.S., Takahashi, T., Nowakowski, R.S., 1995. Numbers, time
and neocortical neuronogenesis: a general developmental and evolu-
tionary model. Trends Neurosci. 18, 379–383.
Chenn, A., Walsh, C.A., 2002. Regulation of cerebral cortical size
by control of cell cycle exit in neural precursors. Science 297,
365–369.
Chi, C.L., Martinez, S., Wurst, W., Martin, G.R., 2003. The isthmic
organizer signal FGF8 is required for cell survival in the prospective
midbrain and cerebellum. Development 130, 2633–2644.
Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G., Ornitz, D.M.,
1996. Skeletal overgrowth and deafness in mice lacking fibroblast
growth factor receptor 3. Nat. Genet. 12, 390–397.
Deng, C.X., Wynshaw-Boris, A., Shen, M.M., Daugherty, C., Ornitz, D.M.,
Leder, P., 1994. Murine FGFR-1 is required for early postimplantation
growth and axial organization. Genes Dev. 8, 3045–3057.
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., Leder, P., 1996.
Fibroblast growth factor receptor 3 is a negative regulator of bone
growth. Cell 84, 911–921.
Dode, C., Levilliers, J., Dupont, J.M., De Paepe, A., Le Du, N., Soussi-
Yanicostas, N., Coimbra, R.S., Delmaghani, S., Compain-Nouaille, S.,
Baverel, F., Pecheux, C., Le Tessier, D., Cruaud, C., Delpech, M.,
Speleman, F., Vermeulen, S., Amalfitano, A., Bachelot, Y., Bouchard,
P., Cabrol, S., Carel, J.C., Delemarre-van de Waal, H., Goulet-Salmon,
B., Kottler, M.L., Richard, O., Sanchez-Franco, F., Saura, R., Young,
J., Petit, C., Hardelin, J.P., 2003. Loss-of-function mutations in
FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet.
33, 463–465.
Dono, R., Texido, G., Dussel, R., Ehmke, H., Zeller, R., 1998. Impaired
cerebral cortex development and blood pressure regulation in FGF-2-
deficient mice. EMBO J. 17, 4213–4225.
Dou, C.L., Li, S., Lai, E., 1999. Dual role of brain factor-1 in regulating
growth and patterning of the cerebral hemispheres. Cereb. Cortex 9,
543–550.
Edlund, T., Jessell, T.M., 1999. Progression from extrinsic to intrinsic
signaling in cell fate specification: a view from the nervous system. Cell
96, 211–224.
Ford-Perriss, M., Abud, H., Murphy, M., 2001. Fibroblast growth factors in
the developing central nervous system. Clin. Exp. Pharmacol. Physiol.
28, 493–503.
Fukuchi-Shimogori, T., Grove, E.A., 2001. Neocortex patterning by the
secreted signaling molecule FGF8. Science 294, 1071–1074.
S.L. Inglis-Broadgate et al. / Developmental Biology 279 (2005) 73–8584Furuta, Y., Piston, D.W., Hogan, B.L., 1997. Bone morphogenetic proteins
(BMPs) as regulators of dorsal forebrain development. Development
124, 2203–2212.
Garel, S., Huffman, K.J., Rubenstein, J.L., 2003. Molecular regionalization
of the neocortex is disrupted in Fgf8 hypomorphic mutants. Develop-
ment 130, 1903–1914.
Hart, K.C., Robertson, S.C., Donoghue, D.J., 2001. Identification of
tyrosine residues in constitutively activated fibroblast growth factor
receptor 3 involved in mitogenesis, Stat activation, and phosphatidy-
linositol 3-kinase activation. Mol. Biol. Cell. 12, 931–942.
Hebert, J.M., Lin, M., Partanen, J., Rossant, J., McConnell, S.K., 2003.
FGF signaling through FGFR1 is required for olfactory bulb morpho-
genesis. Development 130, 1101–1111.
Hevner, R.F., Shi, L., Justice, N., Hsueh, Y., Sheng, M., Smiga, S.,
Bulfone, A., Goffinet, A.M., Campagnoni, A.T., Rubenstein, J.L.,
2001. Tbr1 regulates differentiation of the preplate and layer 6. Neuron
29, 353–366.
Ho, K.L., Chang, C.H., Yang, S.S., Chason, J.L., 1984. Neuropatho-
logic findings in thanatophoric dysplasia. Acta Neuropathol. (Berl). 63,
218–228.
Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R.,
Francomano, C.A., Deng, C.X., 2000. A neonatal lethal mutation in
FGFR3 uncouples proliferation and differentiation of growth plate
chondrocytes in embryos. Hum. Mol. Genet. 9, 1603–1613.
Iwata, T., Li, C.L., Deng, C.X., Francomano, C.A., 2001. Highly activated
Fgfr3 with the K644M mutation causes prolonged survival in severe
dwarf mice. Hum. Mol. Genet. 10, 1255–1264.
Jacobowitz, D.M, Abbott, L.C., 1997. Chemoarchitedtonic atlas of the
developing mouse brain. CRC Press, Florida, USA.
Kaufman, M.H., Bard, J.B.L., 1999. The Anatomical Basis of the Mouse
Development. Academic Press, London.
Kuan, C.Y., Roth, K.A., Flavell, R.A., Rakic, P., 2000. Mechanisms of
programmed cell death in the developing brain. Trends Neurosci. 23,
291–297.
Li, C., Chen, L., Iwata, T., Kitagawa, M., Fu, X.Y., Deng, C.X., 1999. A
Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3)
causes dwarfism in mice by activation of STATs and ink4 cell cycle
inhibitors. Hum. Mol. Genet. 8, 35–44.
Lievens, P.M., Liboi, E., 2003. The thanatophoric dysplasia type II
mutation hampers complete maturation of fibroblast growth factor
receptor 3 (FGFR3), which activates signal transducer and activator of
transcription 1 (STAT1) from the endoplasmic reticulum. J. Biol. Chem.
278, 17344–17349.
Lin, T., Sandusky, S.B., Xue, H., Fishbein, K.W., Spencer, R.G., Rao,
M.S., Francomano, C.A., 2003. A central nervous system specific
mouse model for thanatophoric dysplasia type II. Hum. Mol. Genet. 12,
2863–2871.
Martinez, S., Crossley, P.H., Cobos, I., Rubenstein, J.L., Martin, G.R.,
1999. FGF8 induces formation of an ectopic isthmic organizer and
isthmocerebellar development via a repressive effect on Otx2 expres-
sion. Development 126, 1189–1200.
McLeod, M.J., 1980. Differential staining of cartilage and bone in
whole mouse fetuses by alcian blue and alizarin red S. Teratology 22,
299–301.
Meyers, E.N., Lewandoski, M., Martin, G.R., 1998. An Fgf8 mutant allelic
series generated by Cre- and Flp-mediated recombination. Nat. Genet.
18, 136–141.
Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O., Yayon, A., 2000.
The transmembrane mutation G380R in fibroblast growth factor
receptor 3 uncouples ligand-mediated receptor activation from down-
regulation. Mol. Cell. Biol. 20, 516–522.
Naski, M.C., Wang, Q., Xu, J., Ornitz, D.M., 1996. Graded activation of
fibroblast growth factor receptor 3 by mutations causing achondroplasia
and thanatophoric dysplasia. Nat. Genet. 13, 233–237.
Noctor, S.C., Martinez-Cerdeno, V., Ivic, L., Kriegstein, A.R., 2004.
Cortical neurons arise in symmetric and asymmetric division zones and
migrate through specific phases. Nat. Neurosci. 7, 136–144.Oh, L.Y., Denninger, A., Colvin, J.S., Vyas, A., Tole, S., Ornitz, D.M.,
Bansal, R., 2003. Fibroblast growth factor receptor 3 signaling regulates
the onset of oligodendrocyte terminal differentiation. J. Neurosci. 23,
883–894.
Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A.,
Coulier, F., Gao, G., Goldfarb, M., 1996. Receptor specificity of the
fibroblast growth factor family. J. Biol. Chem. 271, 15292–15297.
Orr-Urtreger, A., Givol, D., Yayon, A., Yarden, Y., Lonai, P., 1991.
Developmental expression of two murine fibroblast growth factor
receptors, flg and bek. Development 113, 1419–1434.
Ortega, S., Ittmann, M., Tsang, S.H., Ehrlich, M., Basilico, C., 1998.
Neuronal defects and delayed wound healing in mice lacking fibroblast
growth factor 2. Proc. Natl. Acad. Sci. U. S. A. 95, 5672–5677.
Peters, K., Ornitz, D., Werner, S., Williams, L., 1993. Unique expression
pattern of the FGF receptor 3 gene during mouse organogenesis. Dev.
Biol. 155, 423–430.
Pirvola, U., Ylikoski, J., Trokovic, R., Hebert, J., McConnell, S., Partanen,
J., 2002. FGFR1 is required for the development of the auditory sensory
epithelium. Neuron 35, 671–680.
Pringle, N.P., Yu, W.P., Howell, M., Colvin, J.S., Ornitz, D.M., Richardson,
W.D., 2003. Fgfr3 expression by astrocytes and their precursors:
evidence that astrocytes and oligodendrocytes originate in distinct
neuroepithelial domains. Development 130, 93–102.
Raballo, R., Rhee, J., Lyn-Cook, R., Leckman, J.F., Schwartz, M.L.,
Vaccarino, F.M., 2000. Basic fibroblast growth factor (Fgf2) is
necessary for cell proliferation and neurogenesis in the developing
cerebral cortex. J. Neurosci. 20, 5012–5023.
Rakic, P., 1995. A small step for the cell, a giant leap for mankind: a
hypothesis of neocortical expansion during evolution. Trends Neurosci.
18, 383–388.
Ross,M.E.,Walsh, C.A., 2001. Human brainmalformations and their lessons
for neuronal migration. Annu. Rev. Neurosci. 24, 1041–1070.
Sasai, Y., Kageyama, R., Tagawa, Y., Shigemoto, R., Nakanishi, S., 1992.
Two mammalian helix-loop-helix factors structurally related to Droso-
phila hairy and Enhancer of split. Genes Dev. 6, 2620–2634.
Schlessinger, J., 2000. Cell signaling by receptor tyrosine kinases. Cell 103,
211–225.
Shimamura, K., Rubenstein, J.L., 1997. Inductive interactions direct early
regionalization of the mouse forebrain. Development 124, 2709–2718.
Shin, D.M., Korada, S., Raballo, R., Shashikant, C.S., Simeone, A., Taylor,
J.R., Vaccarino, F., 2004. Loss of glutamatergic pyramidal neurons in
frontal and temporal cortex resulting from attenuation of FGFR1
signaling is associated with spontaneous hyperactivity in mice.
J. Neurosci. 24, 2247–2258.
Sidman, R.L., Rakic, P., 1973. Neuronal migration, with special reference
to developing human brain: a review. Brain Res. 62, 1–35.
Storm, E.E., Rubenstein, J.L., Martin, G.R., 2003. Dosage of Fgf8 deter-
mines whether cell survival is positively or negatively regulated in the
developing forebrain. Proc. Natl. Acad. Sci. U. S. A. 100, 1757–1762.
Szebenyi, G., Fallon, J.F., 1999. Fibroblast growth factors as multifunc-
tional signaling factors. Int. Rev. Cytol. 185, 45–106.
Takahashi, T., Nowakowski, R.S., Caviness Jr., V.S., 1993. Cell cycle
parameters and patterns of nuclear movement in the neocortical
proliferative zone of the fetal mouse. J. Neurosci. 13, 820–833.
Takahashi, T., Nowakowski, R.S., Caviness Jr., V.S., 1995. The cell cycle of
the pseudostratified ventricular epithelium of the embryonic murine
cerebral wall. J. Neurosci. 15, 6046–6057.
Tavormina, P.L., Bellus, G.A., Webster, M.K., Bamshad, M.J., Fraley, A.E.,
McIntosh, I., Szabo, J., Jiang, W., Jabs, E.W., Wilcox, W.R., Wasmuth,
J.J., Donoghue, D.J., Thompson, L.M., Francomano, C.A., 1999. A
novel skeletal dysplasia with developmental delay and acanthosis
nigricans is caused by a Lys650Met mutation in the fibroblast growth
factor receptor 3 gene. Am. J. Hum. Genet. 64, 722–731.
Temple, S., 2001. The development of neural stem cells. Nature 414,
112–117.
Temple, S., Qian, X., 1995. bFGF, neurotrophins, and the control or cortical
neurogenesis. Neuron 15, 249–252.
S.L. Inglis-Broadgate et al. / Developmental Biology 279 (2005) 73–85 85Trokovic, R., Trokovic, N., Hernesniemi, S., Pirvola, U., Vogt Weisenhorn,
D.M., Rossant, J., McMahon, A.P., Wurst, W., Partanen, J., 2003.
FGFR1 is independently required in both developing mid-and hindbrain
for sustained response to isthmic signals. EMBO J. 22, 1811–1823.
Vaccarino, F.M., Schwartz, M.L., Raballo, R., Nilsen, J., Rhee, J., Zhou,
M., Doetschman, T., Coffin, J.D., Wyland, J.J., Hung, Y.T., 1999.
Changes in cerebral cortex size are governed by fibroblast growth factor
during embryogenesis. Nat. Neurosci. 2, 246–253.
Webster, M.K., D’Avis, P.Y., Robertson, S.C., Donoghue, D.J., 1996.
Profound ligand-independent kinase activation of fibroblast growth
factor receptor 3 by the activation loop mutation responsible for a lethal
skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16,
4081–4087.Wongmongkolrit, T., Bush, M., Roessmann, U., 1983. Neuropatholo-
gical findings in thanatophoric dysplasia. Arch. Pathol. Lab. Med. 107,
132–135.
Yamaguchi, T.P., Harpal, K., Henkemeyer, M., Rossant, J., 1994. fgfr-1 is
required for embryonic growth and mesodermal patterning during
mouse gastrulation. Genes Dev. 8, 3032–3044.
Yazaki, N., Hosoi, Y., Kawabata, K., Miyake, A., Minami, M., Satoh, M.,
Ohta, M., Kawasaki, T., Itoh, N., 1994. Differential expression patterns
of mRNAs for members of the fibroblast growth factor receptor family,
FGFR-1-FGFR-4, in rat brain. J. Neurosci. Res. 37, 445–452.
Ye, W., Shimamura, K., Rubenstein, J.L., Hynes, M.A., Rosenthal, A.,
1998. FGF and Shh signals control dopaminergic and serotonergic cell
fate in the anterior neural plate. Cell 93, 755–766.
